| Basics |
Pfizer Inc.
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$148B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.27 | 0.89%
|
| Avg Daily Range (30 D): |
$0.25 | 1.00%
|
| Avg Daily Range (90 D): |
$0.27 | 1.07%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
30.79M |
| Avg Daily Volume (30 D): |
73.44M |
| Avg Daily Volume (90 D): |
54.4M |
| Trade Size |
| Avg Trade Size (Sh.): |
310 |
| Avg Trade Size (Sh.) (30 D): |
375 |
| Avg Trade Size (Sh.) (90 D): |
311 |
| Institutional Trades |
| Total Inst.Trades: |
366,635 |
| Avg Inst. Trade: |
$3.48M |
| Avg Inst. Trade (30 D): |
$3.8M |
| Avg Inst. Trade (90 D): |
$3.88M |
| Avg Inst. Trade Volume: |
.12M |
| Avg Inst. Trades (Per Day): |
65 |
| Market Closing Trades |
| Avg Closing Trade: |
$80.72M |
| Avg Closing Trade (30 D): |
$127.94M |
| Avg Closing Trade (90 D): |
$111.5M |
| Avg Closing Volume: |
2.52M |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$1.73
|
$.62
|
$.51
|
|
Diluted EPS
|
$1.72
|
$.62
|
$.51
|
|
Revenue
|
$ 62.79B
|
$ 16.65B
|
$ 14.65B
|
|
Gross Profit
|
$ 46.08B
|
$ 12.48B
|
$ 10.88B
|
|
Net Income / Loss
|
$ 9.87B
|
$ 3.55B
|
$ 2.93B
|
|
Operating Income / Loss
|
$ 9.15B
|
$ 3.33B
|
$ 3.04B
|
|
Cost of Revenue
|
$ 16.7B
|
$ 4.17B
|
$ 3.78B
|
|
Net Cash Flow
|
$ 242M
|
$ -302M
|
$ 214M
|
|
PE Ratio
|
15.10
|
|
|
|
|
|